For hepatocellular carcinoma (HCC), whole-genome sequencing analysis revealed that single-nucleotide variations (rs2257212) of SLC15A2 demonstrated better progression-free survival and regulated the sorafenib treatment response (Lee et al., 2015). Here, SLC15A2 is linked to hepatocellular carcinoma.